4/A//SEC Filing
Furiex Pharmaceuticals, Inc. 4/A
Accession 0001437749-13-012117
CIK 0001484478operating
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 9:43 PM ET
Size
4.8 KB
Accession
0001437749-13-012117
Insider Transaction Report
Form 4/AAmended
McIntyre Gail Frances
Senior Vice President-Research
Transactions
- Sale
Common Stock
2013-07-19$40.00/sh−20,000$800,000→ 17,868 total
Footnotes (1)
- [F1]This sale was pursuant to a Rule 10b5-1 Sales Plan, which is intended to comply with Rule 10b5-1.
Documents
Issuer
Furiex Pharmaceuticals, Inc.
CIK 0001484478
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001484478
Filing Metadata
- Form type
- 4/A
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 9:43 PM ET
- Size
- 4.8 KB